DocMorris (OTCMKTS:ZRSEF) Shares Down 31.7% – Here’s Why

DocMorris AG (OTCMKTS:ZRSEF) was down 31.7% during mid-day trading on Friday . The stock traded as low as $7.4540 and last traded at $7.4540. Approximately 700 shares changed hands during trading, an increase of 100% from the average daily volume of 350 shares. The stock had previously closed at $10.91.

Analyst Upgrades and Downgrades

Separately, Barclays began coverage on DocMorris in a research report on Tuesday, October 7th. They issued a “positive” rating for the company. One investment analyst has rated the stock with a Buy rating, According to MarketBeat, the stock presently has an average rating of “Buy”.

DocMorris Stock Down 31.7%

The company’s 50 day simple moving average is $10.18 and its two-hundred day simple moving average is $10.41.

About DocMorris

DocMorris is a leading European online pharmacy brand and a subsidiary of the Swiss-based Zur Rose Group (OTCMKTS:ZRSEF). Through its digital platform, the company offers mail-order dispensing of prescription medications and over-the-counter health products directly to consumers’ homes.

The company’s core services include the online sale and delivery of prescription and non-prescription drugs, health supplements, personal care items and medical devices. Leveraging its e-commerce infrastructure and proprietary pharmacy management systems, DocMorris also provides digital health solutions such as telemedicine consultations, medication management tools and mobile app-based healthcare services.

Originally launched in the early 2000s in Germany, DocMorris has expanded its reach to serve customers in multiple European countries, including the Netherlands, Belgium, Luxembourg and Switzerland.